| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.81M | 13.61M | 87.14M | 21.30M | 38.92M | 30.66M |
| Gross Profit | 2.02M | 1.91M | 67.57M | 2.06M | 17.09M | 12.08M |
| EBITDA | 3.40B | 3.40B | -388.90M | -29.31M | 19.61M | 321.99M |
| Net Income | 3.72B | 3.36B | -404.61M | -418.77M | 13.42M | 337.18M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 5.43B | 5.49B | 2.09B | 2.60B | 2.61B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 209.56M | 21.05M | 134.68M | 167.95M | 144.44M |
| Total Debt | 0.00 | 3.18M | 62.84M | 3.96M | 3.18M | 3.18M |
| Total Liabilities | -4.66B | 772.72M | 878.53M | 960.67M | 1.10B | 1.12B |
| Stockholders Equity | 4.66B | 4.66B | 4.61B | 1.13B | 1.50B | 1.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -52.04M | -88.64M | -76.96M | -22.89M | 8.59M |
| Operating Cash Flow | 0.00 | -43.01M | -88.64M | -76.90M | -22.67M | 8.65M |
| Investing Cash Flow | 0.00 | 69.21M | 62.88M | 52.54M | 5.60M | -68.00K |
| Financing Cash Flow | 0.00 | -1.80M | 1.04M | 7.35M | 12.07M | 5.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹1.13B | -15.68 | ― | ― | 28.58% | 68.42% | |
71 Outperform | ₹1.38B | 20.15 | ― | ― | -18.35% | -43.75% | |
57 Neutral | ₹1.60B | 7.59 | ― | ― | -6.94% | -97.47% | |
56 Neutral | ₹2.07B | 27.36 | ― | ― | 14.93% | -24.77% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
49 Neutral | ₹1.65B | 1.72 | ― | ― | ― | ― |
Maha Rashtra Apex Corporation Limited has announced the allocation of a dedicated International Securities Identification Number, INE843B20013, for rights entitlements linked to its upcoming rights issue. In line with SEBI’s rights issue regulations, the company has coordinated with depositories NSDL and CDSL to ensure that eligible equity shareholders receive their rights entitlements in dematerialized form in their demat accounts before the issue opens, streamlining participation and reinforcing compliance with market norms.
Maha Rashtra Apex Corporation Limited’s board has approved a fully paid rights issue of equity shares at par value, offering one new share for every existing share held as of the March 20, 2026 record date. The rights shares are priced at ₹10 each, with the full amount payable on application, and the issue period is scheduled from April 2 to April 30, 2026, subject to possible extension within regulatory limits.
The company plans to issue up to 14,091,896 new equity shares, targeting an issue size of up to ₹1,409.19 lakhs and potentially doubling its outstanding share capital to 28,183,792 shares on full subscription. This capital-raising move, enabled by recent in-principle approvals from both major Indian exchanges and supported by an appointed advisor, is set to expand the shareholder base and could enhance liquidity in the stock while modestly diluting existing holdings for non-participating investors.
Maha Rashtra Apex Corporation Limited has set March 20, 2026 as the record date to determine eligible shareholders for receiving rights entitlements in an upcoming rights issue of equity shares. The move, approved by the board on March 11, 2026 and disclosed to both BSE and NSE, clarifies which investors will qualify to participate in the capital-raising exercise, providing transparency for existing stakeholders ahead of the rights offer.
By fixing the record date and formally notifying the exchanges, the company is advancing its planned rights issue process in line with SEBI listing regulations. This step signals an imminent equity fundraising that could strengthen the company’s capital base, while also potentially diluting non-participating shareholders, making the record date a key reference point for investors tracking their entitlements.